Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-004412
Filing Date
2012-05-03
Accepted
2012-05-03 08:00:57
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nova_10q-033112.htm 10-Q 839995
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 11218
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 11021
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5156
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5657
  Complete submission text file 0001437749-12-004412.txt   3102615

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nby-20120331.xml EX-101.INS 477698
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nby-20120331.xsd EX-101.SCH 14343
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nby-20120331_cal.xml EX-101.CAL 32101
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nby-20120331_def.xml EX-101.DEF 83108
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nby-20120331_lab.xml EX-101.LAB 106325
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nby-20120331_pre.xml EX-101.PRE 85017
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: CA | Fiscal Year End: 0120
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 12807408
SIC: 2834 Pharmaceutical Preparations